FDA approves Zevra’s rare disease drug after resubmission

After a second review, the FDA approved Zevra Therapeutics’ treatment for Niemann-Pick disease type C, a progressive rare genetic disease caused by the accumulation of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

UCB SA Patent: Treating Systemic Lupus Erythematosus with Anti-CD154 Antibody

Share this article According to GlobalData’s company profile on UCB, Human telomerase RT biomarker was a key innovation area identified from patents. UCB‘s grant share

April 1, 2024

Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland – Biotech Investments

Xlife Sciences AG / Key word(s): Alliance/Contract Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland 03.04.2024 / 17:00

April 5, 2024

Pemafibrate Takes a Small Step Forward in Diabetic Foot Ulcers After CVD Flop

Pemafibrate was tied to potential prevention of leg and foot ulcers in type 2 diabetes, a silver lining to the PROMINENT trial’s otherwise disappointing cardiovascular

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.